We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.5B
AUM Growth
+$1.97B
Cap. Flow
+$2.02B
Cap. Flow %
9.42%
Top 10 Hldgs %
32.39%
Holding
905
New
41
Increased
563
Reduced
263
Closed
35

Top Sells

Rank Stock Value
1
HL icon
Hecla Mining
HL
+$172M
2
CDE icon
Coeur Mining
CDE
+$159M
3
AG icon
First Majestic Silver
AG
+$153M
4
APC
Anadarko Petroleum
APC
+$143M
5
BTG icon
B2Gold
BTG
+$73.3M

Sector Composition

Rank Sector Weight
1 Materials 57.23%
2 Energy 17.25%
3 Healthcare 5.12%
4 Technology 3.03%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESV
101
DELISTED
Ensco Rowan plc
ESV
$30.8M 0.14%
906,858
+157,226
+21% +$5.35M
NXPI icon
102
NXP Semiconductors
NXPI
$68B
$29.3M 0.14%
287,369
+108,593
+61% +$9.2M
ILMN icon
103
Illumina
ILMN
$29.4B
$29.2M 0.14%
165,087
-7,825
-5% -$1.25M
TXN icon
104
Texas Instruments
TXN
$255B
$28.9M 0.13%
412,315
+112,250
+37% +$7.65M
CPE
105
DELISTED
Callon Petroleum Company
CPE
$28.1M 0.13%
+179,180
New +$23.7M
NVDA icon
106
NVIDIA
NVDA
$5.01T
$27.4M 0.13%
16,008,960
+1,993,160
+14% +$2.94M
HTHT icon
107
Huazhu Hotels Group
HTHT
$12.4B
$27.1M 0.13%
2,404,000
+1,164,000
+94% +$12.2M
REGN icon
108
Regeneron Pharmaceuticals
REGN
$68.8B
$27.1M 0.13%
67,377
-1,902
-3% -$763K
ALXN
109
DELISTED
Alexion Pharmaceuticals
ALXN
$26.4M 0.12%
215,393
+40,759
+23% +$5.25M
OII icon
110
Oceaneering
OII
$5.25B
$26.3M 0.12%
956,870
+141,986
+17% +$3.93M
BMRN icon
111
BioMarin Pharmaceuticals
BMRN
$11.5B
$25.9M 0.12%
280,253
-8,131
-3% -$766K
SLCA
112
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$25.7M 0.12%
552,250
+96,579
+21% +$3.76M
MSFT icon
113
Microsoft
MSFT
$2.84T
$25.7M 0.12%
446,114
+31,942
+8% +$1.8M
ASML icon
114
ASML
ASML
$675B
$25.7M 0.12%
234,085
+56,271
+32% +$5.96M
ACAD icon
115
Acadia Pharmaceuticals
ACAD
$4.25B
$25.3M 0.12%
+796,521
New +$27M
AMAT icon
116
Applied Materials
AMAT
$426B
$25.1M 0.12%
832,143
+164,380
+25% +$4.59M
VRTX icon
117
Vertex Pharmaceuticals
VRTX
$121B
$24.6M 0.11%
281,836
+25,434
+10% +$2.4M
INCY icon
118
Incyte
INCY
$23.5B
$24.4M 0.11%
259,076
-25,546
-9% -$2.15M
BG icon
119
Bunge Global
BG
$23.6B
$23.9M 0.11%
403,746
+21,313
+6% +$1.33M
RSPP
120
DELISTED
RSP Permian, Inc.
RSPP
$23.2M 0.11%
597,100
-16,800
-3% -$621K
TSCO icon
121
Tractor Supply
TSCO
$16.3B
$23M 0.11%
1,705,380
+190
+0% +$3.16K
MU icon
122
Micron Technology
MU
$1.04T
$22.8M 0.11%
1,283,170
+248,380
+24% +$3.79M
ADI icon
123
Analog Devices
ADI
$181B
$22.6M 0.11%
349,958
+80,680
+30% +$5M
INVX
124
Innovex International
INVX
$1.87B
$22.3M 0.1%
400,813
+66,421
+20% +$3.7M
MOS icon
125
The Mosaic Company
MOS
$7.09B
$21.7M 0.1%
888,268
-36,672
-4% -$1,000K

Similar funds

VanEck Associates's Q3 2016 Portfolio in Review

As of Q3 2016, VanEck Associates held 905 positions worth $21.5B, up 10% from $19.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

VanEck Associates deployed $2.02B of net new capital in Q3 2016, opening 41 new positions and adding to 563 existing holdings. Its largest new stake was OR Royalties Inc: 19,336,954 shares worth $212M.

By sector, the portfolio is most concentrated in Materials at 57% of assets, down from 58% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Hecla Mining, an estimated $172M trimmed.

  • VanEck Associates's largest Q3 2016 buy was OR Royalties Inc: 19,336,954 shares worth $212M.
  • VanEck Associates added most to Newmont in Q3 2016, an estimated $134M increase.
  • VanEck Associates's biggest Q3 2016 reduction was Hecla Mining, cutting an estimated $172M.
  • VanEck Associates fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $24.3M.
  • VanEck Associates's ten largest holdings make up 32% of its $21.5B portfolio in Q3 2016.
  • VanEck Associates opened 41 new positions and closed 35 in Q3 2016.
  • VanEck Associates's portfolio value rose 10% quarter-over-quarter to $21.5B.

Based on VanEck Associates's 13F filing for Q3 2016, filed 14 Nov 2016.